In an advance that sheds light on why certain vaccines may influence people differently, a new computational approach developed at the University of Michigan may predict how individual patients are likely to respond.
Sep 2, 2021
0
173
A team led by the Duke Human Vaccine Institute (DHVI) has developed a vaccine approach that works like a GPS, guiding the immune system through the specific steps to make broadly neutralizing antibodies against HIV.
May 9, 2024
0
12
A University of Birmingham-led study supported by the UK Coronavirus Immunology Consortium has found that 98% of people aged 80 or over who had two doses of the Pfizer COVID-19 vaccine had a strong antibody immune response.
Apr 1, 2021
0
5
Combination vaccines for young children are commonly used in industrialized nations because they provide protection for multiple diseases in one single injection. However, combination vaccines are prohibitively expensive ...
May 9, 2011
0
0
As Streptococcus A cases continue to be prevalent in Queensland and internationally, a new nasal vaccine could provide long-term protection from the deadly bacteria.
Oct 5, 2023
0
16
(Medical Xpress) -- Scientists in Trinity College Dublin, Ireland, have developed a new vaccine to treat cancer at the pre-clinical level. The research team led by Professor Kingston Mills, Professor of Experimental Immunology ...
Dec 21, 2011
0
0
Treatment with a HER2-targeted therapeutic cancer vaccine provided clinical benefit to several patients with metastatic HER2-positive cancers who had not previously been treated with a HER2-targeted therapeutic, according ...
Sep 30, 2018
0
1
Long before the Zika virus became a global fear, cytomegalovirus, or CMV, was commonly infecting developing fetuses and causing many of the same brain and developmental impairments.
Jul 6, 2017
0
27
An MIT research team led by Professor Darrell Irvine has developed a novel kind of vaccine adjuvant: A nanoparticle that can help to stimulate the immune system to generate a stronger response to a vaccine. These nanoparticles ...
Dec 12, 2023
0
0
Research toward the world's first vaccine for heart disease continues to advance at the La Jolla Institute for Allergy and Immunology, with researchers demonstrating significant arterial plaque reduction in concept testing ...
Jun 17, 2014
0
0
